Celldex Therapeutics, Inc. Common Stock Shares Outstanding

• Celldex Therapeutics, Inc. showed an increase of +0.3% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Celldex Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2011: 44.15 million shares | Q3 2011: 44.15 million shares | Q1 2012: 58.74 million shares | Q2 2012: 58.75 million shares | Q3 2012: 60.81 million shares | Q1 2013: 80.87 million shares | Q2 2013: 80.98 million shares | Q3 2013: 81.11 million shares | Q1 2014: 89.36 million shares | Q2 2014: 89.40 million shares | Q3 2014: 89.44 million shares | Q1 2015: 98.48 million shares | Q2 2015: 98.55 million shares | Q3 2015: 98.65 million shares | Q1 2016: 98.72 million shares | Q2 2016: 99.39 million shares | Q3 2016: 101.25 million shares | Q1 2017: 124.17 million shares | Q2 2017: 127.41 million shares | Q3 2017: 132.11 million shares | Q1 2018: 143.37 million shares | Q2 2018: 156.65 million shares | Q3 2018: 168.58 million shares | Q1 2019: 12.84 million shares | Q2 2019: 14.82 million shares | Q3 2019: 15.90 million shares | Q1 2020: 17.73 million shares | Q2 2020: 39.09 million shares | Q3 2020: 39.56 million shares | Q1 2021: 39.61 million shares | Q2 2021: 39.62 million shares | Q3 2021: 46.66 million shares | Q1 2022: 46.75 million shares | Q2 2022: 46.76 million shares | Q3 2022: 47.10 million shares | Q1 2023: 47.24 million shares | Q2 2023: 47.25 million shares | Q3 2023: 47.26 million shares | Q1 2024: 65.91 million shares | Q2 2024: 66.28 million shares | Q3 2024: 66.34 million shares | Q1 2025: 66.38 million shares | Q2 2025: 66.39 million shares | Q3 2025: 66.45 million shares.
• Over the full 16 years of available data (2010 to 2025), Celldex Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 107.6%.
• Historical annual values: Fiscal year 2025: 66.55 million shares | Fiscal year 2024: 66.37 million shares | Fiscal year 2023: 55.88 million shares | Fiscal year 2022: 47.20 million shares | Fiscal year 2021: 46.73 million shares | Fiscal year 2020: 39.60 million shares | Fiscal year 2019: 16.97 million shares | Fiscal year 2018: 11.96 million shares | Fiscal year 2017: 9.23 million shares | Fiscal year 2016: 120.52 million shares | Fiscal year 2015: 98.69 million shares | Fiscal year 2014: 89.59 million shares | Fiscal year 2013: 89.25 million shares | Fiscal year 2012: 64.36 million shares | Fiscal year 2011: 44.21 million shares | Fiscal year 2010: 32.06 million shares.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026